Public M&A (sell-side)

• Representation of Deliveroo plc on its recommended £2.9 billion all-cash acquisition by NYSE-listed DoorDash, Inc.
• Representation of IQE, the leading supplier of advanced wafer products and material solutions to the semiconductor indtry, on its strategic review
• Representation of Ocean Outdoor Limited in connection with Atairos' US$580 million takeover by way of BVI statutory merger
• Representation of Monitise in connection with Fiserv's £75 million takeover offer for Monitise

Public M&A (buy-side)

• Representation of Goldman Sachs International on its US$1.72 billion take private of Kahoot! ASA.
• Representation of Echostar in connection with its £3.2 billion approach to Inmarsat plc
• Representation of Antin Infrastructure Partners and Goldman Sachs' West Street Infrastructure Partners in connection with their £540 million takeover offer for CityFibre
• Representation of UBS in connection with Ion Capital's £1.5 billion takeover offer for Fidessa
• Representation of Standard Chartered Bank in connection with with PT Medco Energi Internasional Tbk's £400 million takeover offer for Ophir Energy plc

Equity Capital Markets

• Representation of each of Crystal Peak Acquisitions and Ahren Acquisition Corp (both SPACs) on their respective IPOs on Euroclear Amsterdam and Nasdaq respectively
• Representation of the African Export Import Bank on its proposed London IPO plans which will be a first of its kind for a multi-lateral development bank on a major exchange
• Representation of Avast on its IPO with a market capitalization on listing of US$3.23 billion
• Representation of DiscoverIE plc on its £30 million cashbox placing
• Representation of IQE, the leading supplier of advanced wafer products and material solutions to the semiconductor indtry, on its £100 million cash placing and £18 million convertible loan note financing

Private M&A / Joint Ventures

• Representation of Smiths Group plc on three separate divisional carve-outs:
  • the sale of Smiths Interconnect division to Molex Electronic Technologies Holdings, LLC, a Koch company for US$1.8 billion
  • the sale of Smiths Detection division to CVC for US$2.7 billion
  • the sale of Smiths Medical to ICU Medical, Inc. for US$3 billion
• Representation of Deliveroo plc on the sale of its Hong Kong operations to Delivery Hero and ultimate exit of the Hong Kong market
• Representation of Venterra, a dedicated offshore wind energy services company, on its £40 million capital raising
• Representation of SYSPRO Group, a leading global ERP software provider for the manufacturing and distribution indtries, on its sale to Advent International
• Representation of Motive Partners, a pure play fintech PE fund, on its acquisition of the With Intelligence group, a leading provider of data, intelligence and connections to the global asset management indtry
• Representation of LSE listed discoverIE Group plc on the sale of its Ctom Supply distribution biness (Acal BFi) to H2 Equity Partners
• Representation of Paysafe Group on all corporate and securities matters and M&A including its acquisition of Viafintech, one of the largest bank-independent alternative payments infrastructures in Europe and the sale of its technology operations in India.
• Representation of Pollinate, a new merchant acquiring technology company, on its establishment and funding rounds raising, in aggregate, over US$200 million including investments from RBS, MasterCard, Fiserv, CIBC, NAB and EFM Asset Management
• Representation of Elliott Management in the restructuring (including a debt for equity swap) of the South American airlines biness, Avianca Holdings, S.A.
• Representation of Prism Group AG, a Dubai based fintech group (acting in consortium Royal Strategic Partners) on its acquisition of the LSE listed Finablr Group, a global financial services platform and on its acquisition of the BFC (the Bahrain Finance Corporation), a regional payments and remittance biness
• Representation of European Bank for Reconstruction and Development (EBRD) as a founding investor on the creation of a US$750 million biopharmaceutical platform to broaden access to vital specialty generic drugs in Africa